Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.8K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advanced 3D cancer models for analyzing tumor-immune cell interaction and therapeutic response.

Molecular cancer·2026
Same author

Bottom-Up Programming of Cell States in Cancer Organoids with Defined Synthetic Adhesion Cues.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

GOT1 Inhibition Induces Extracellular Matrix Remodeling in Pancreatic Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Matrix stiffness shapes transcriptional profiles and drug responses of pancreatic cancer cells.

Acta biomaterialia·2025
Same author

A biomaterial-based platform of pancreatic cancer reveals kallikrein-related peptidase 6 (KLK6) as a mediator of neutrophil recruitment and immunosuppression.

Biomaterials·2025
Same author

Tailoring metabolic activity assays for tumour-engineered 3D models.

Biomaterials advances·2024

Related Experiment Video

Updated: Oct 26, 2025

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

2.9K

3D Models for Ovarian Cancer.

Verena Kast1, Daniela Loessner2,3,4,5

  • 1Leibniz Institute of Polymer Research Dresden, Max Bergmann Center of Biomaterials Dresden, Hohe Straβe, Dresden, Germany.

Advances in Experimental Medicine and Biology
|August 2, 2021
PubMed
Summary

Developing better ovarian cancer models is crucial for improving patient survival. Advanced 3D cell culture techniques help researchers understand the tumor microenvironment and test new therapies.

Keywords:
3D cell cultureCancer-on-a-chipHydrogelsOrganoidsOrganotypic culturesScaffoldsSpheroidsTumour microenvironment

More Related Videos

Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice
11:34

Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice

Published on: February 18, 2017

8.9K
Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

15.2K

Related Experiment Videos

Last Updated: Oct 26, 2025

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

2.9K
Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice
11:34

Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice

Published on: February 18, 2017

8.9K
Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

15.2K

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Cell Biology

Background:

  • Ovarian cancer survival rates have stagnated due to "one-size-fits-all" treatments and inadequate experimental models for advanced disease stages.
  • The tumor microenvironment significantly impacts ovarian cancer's peritoneal spread and therapeutic response.
  • Three-dimensional (3D) cell culture models are emerging as vital tools for studying the tumor microenvironment in cancer progression and treatment.

Purpose of the Study:

  • To describe the ovarian cancer tumor microenvironment.
  • To review advanced 3D cell culture models for ovarian cancer research.
  • To highlight methods mimicking the tumor microenvironment for improved therapeutic development.

Main Methods:

  • Review of existing literature on ovarian cancer tumor microenvironment.
  • Description of various 3D cell culture models: spheroids, organoids, and organotypic models.
  • Discussion of enabling technologies: hydrogels, scaffolds, and cancer-on-a-chip devices.

Main Results:

  • The tumor microenvironment plays a critical role in ovarian cancer progression and treatment resistance.
  • 3D culture models offer a more biologically relevant platform than traditional 2D cultures.
  • Various innovative tools are being developed to better recapitulate the complex tumor microenvironment in vitro.

Conclusions:

  • Advanced 3D cell culture models are essential for overcoming limitations in current ovarian cancer research.
  • Mimicking the tumor microenvironment in experimental models is key to developing more effective ovarian cancer therapies.
  • Further development and application of these models promise to accelerate progress in ovarian cancer treatment and improve patient outcomes.